Total Funding
8
Total FundingSeries C raised
Growth Score in past quarter
pts
Heat Score 8 in past quarter
1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
296264
Ariosa Diagnostics is a molecular diagnostics company focused on improving patient care.
Acquired by 

Bio-Reference Laboratories
John Stuelpnagel: Executive ChairmanPast Role: CW Group, Venture Capitalist
About the Company
Ariosa Diagnostics is a non invasive prenatal screening (NIPS) test, the Harmony Prenatal Test, which is one of the most widely studied tests utilized in prenatal screening.


